Press Releases
Search by:
Latest Press Releases   Get News Alerts by RSS
 
> View All Press Releases
RSS
January 28, 2010
Strong Operational and Strategic Performance in Fourth Quarter Caps Transformative 2009
January 25, 2010
European Commission Approves ORENCIA® (abatacept) in Combination with Methotrexate for Children with Moderate to Severe Polyarticular Juvenile Idiopathic Arthritis (pJIA)
January 06, 2010
Bristol-Myers Squibb to Present at J.P. Morgan Healthcare Conference
January 05, 2010
Bristol-Myers Squibb to Announce Results For the Fourth Quarter and Full Year of 2009 on January 28
December 23, 2009
Bristol-Myers Squibb Updates 2009 Continuing Operations Financial Guidance
December 23, 2009
Bristol-Myers Squibb and Mead Johnson Announce Final Results of the Exchange Offer
December 21, 2009
Bristol-Myers Squibb Announces Dividend Increase
December 18, 2009
Bristol-Myers Squibb and Mead Johnson Announce Preliminary Results of the Exchange Offer
December 16, 2009
Bristol-Myers Squibb Sets Exchange Ratio of 0.6313 for the Exchange Offer
December 14, 2009
Bristol-Myers Squibb Announces Appointment of Charles Bancroft as Acting Chief Financial Officer
December 07, 2009
Facet Biotech and Bristol-Myers Squibb Report Promising Phase I/II Interim Data for Elotuzumab in Patients with Relapsed Multiple Myeloma
December 04, 2009
Bristol-Myers Squibb and Mead Johnson Announce Amendment and Extension of Exchange Offer
December 04, 2009
Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixaban In Europe
December 02, 2009
New Data on Bristol-Myers Squibb Oncology Compounds to be Featured in Oral Presentations at 51st Annual Meeting of the American Society of Hematology
November 30, 2009
Translations Available
New Initiative: “Positive Charge” to Help Address Barriers and Provide Support to People Living with HIV/AIDS
November 30, 2009
New Initiative: “Positive Charge” to Help Address Barriers and Provide Support to People Living with HIV/AIDS
November 20, 2009
U.S. Food and Drug Administration Approves ABILIFY® (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
November 15, 2009
Bristol-Myers Squibb Announces Split-Off of Mead Johnson
November 10, 2009
Bristol-Myers Squibb to Present at Credit Suisse Healthcare Conference
November 10, 2009
Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic
November 05, 2009
FDA Approves Labeling Update for REYATAZ® (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients
October 31, 2009
BARACLUDE® (entecavir) Demonstrated Greater Antiviral Efficacy Compared to Adefovir in New Study of Chronic Hepatitis B Patients with Evidence of Decompensated Cirrhosis
October 31, 2009
Bristol-Myers Squibb and ZymoGenetics Present Final Phase 1b Results for PEG-Interferon Lambda in Hepatitis C
October 29, 2009
Photo
Bristol-Myers Squibb Donation to Benefit Students at The Pennington School and Beyond
October 26, 2009
Medarex, Inc. Announces Expiration of Offer to Repurchase its 2.25% Convertible Senior Notes due May 15, 2011
1 2 3 4 5 6 7 8 9 10 11 ... 23
 
Next »
RSS